Treatment failure patterns of adjuvant gefitinib therapy and minimal residual disease detection in resected EGFR-mutant non-small cell lung cancer: author’s reply

por Xu, Song-Tao, Yin, Jia-Cheng, Xi, Jun-Jie, Wang, Qun, Zhong, Wen-Zhao, Wu, Yi-Long
Publicado 2020

A Novel Risk prediction Model for Patients with Combined Hepatocellular-Cholangiocarcinoma

por Tian, Meng-Xin, He, Wen-Jun, Liu, Wei-Ren, Yin, Jia-Cheng, Jin, Lei, Tang, Zheng, Jiang, Xi-Fei, Wang, Han, Zhou, Pei-Yun, Tao, Chen-Yang, Ding, Zhen-Bin, Peng, Yuan-Fei, Dai, Zhi, Qiu, Shuang-Jian, Zhou, Jian, Fan, Jia, Shi, Ying-Hong
Publicado 2018

Development and validation of a prognostic score predicting recurrence in resected combined hepatocellular cholangiocarcinoma

por Tian, Meng-Xin, Luo, Liu-Ping, Liu, Wei-Ren, Deng, Wei, Yin, Jia-Cheng, Jin, Lei, Jiang, Xi-Fei, Zhou, Yu-Fu, Qu, Wei-Feng, Tang, Zheng, Wang, Han, Tao, Chen-Yang, Fang, Yuan, Qiu, Shuang-Jian, Zhou, Jian, Liu, Jing-Feng, Fan, Jia, Shi, Ying-Hong
Publicado 2019